{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:22:14Z","timestamp":1794648134694,"version":"4.9.1"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Osteosarcoma (OS) is a highly aggressive primary bone malignancy that predominantly affects children and adolescents. Although surgical intervention and neoadjuvant therapy demonstrate efficacy in localized OS, postoperative survival rates remain suboptimal for patients with metastatic and recurrent OS. In recent years, immunotherapy has garnered considerable attention due to its promising efficacy across various solid tumors. However, the distinct immunosuppressive tumor microenvironment in OS restricts therapeutic response, as immunosuppressive states are further intensified in metastatic and recurrent lesions, thereby complicating immunotherapy efforts. Recent studies have found that metabolic reprogramming plays a crucial role in shaping the immunosuppressive tumor microenvironment of OS. Tumor cells can induce adaptive metabolic changes in immune cells through competitively consuming nutrients, accumulating immunosuppressive metabolites, and secreting exosomes. This subsequently diminishes their immune functions and promotes immune escape, which partially explains the poor efficacy of immunotherapy in OS. Thus, combining immunotherapy and metabolic-targeted drugs is a potential strategy for enhancing treatment efficacy against OS. This review focuses on the major characteristics of the immunosuppressive microenvironment in OS. It details how metabolic reprogramming in glucose, lipid, and amino acid metabolism remodels this environment and influences key immune cells, including tumor-associated macrophages (TAMs), T cells, and natural killer (NK) cells. It further explores the translational potential of combining metabolic interventions with immunotherapy to advance the clinical application in OS.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1818745","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:53:12Z","timestamp":1780030392000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic\u2013immune crosstalk in osteosarcoma: mechanisms and therapeutic opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Xihan","family":"Wan","sequence":"first","affiliation":[{"name":"Key Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"He","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Chongqing University Cancer Hospital, School of Medicine, Chongqing University","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baicheng","family":"He","sequence":"additional","affiliation":[{"name":"Key Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Pharmacology, School of Pharmacy, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Bone and Soft Tissue Tumors, Chongqing University Cancer Hospital, School of Medicine, Chongqing University","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq276","article-title":"Osteosarcoma","volume":"21","author":"Ritter","year":"2010","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat Rev Dis Primer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2103423","article-title":"New horizons in the treatment of osteosarcoma","volume":"385","author":"Meltzer","year":"2021","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30214-5","article-title":"Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial","volume":"17","author":"Marina","year":"2016","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"21","author":"Kager","year":"2003","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0903","article-title":"A phase I study of APX005M and Cabiralizumab with or without Nivolumab in patients with melanoma, kidney cancer, or non\u2013small cell lung cancer resistant to anti-PD-1\/PD-L1","volume":"27","author":"Weiss","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30729-6","article-title":"CAR T-cell product performance in haematological Malignancies before and after marketing authorisation","volume":"21","author":"Elsallab","year":"2020","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1186\/s12885-023-11390-4","article-title":"Exploratory study of an anti-PD-L1\/TGF-\u03b2 antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)","volume":"23","author":"Xie","year":"2023","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30023-1","article-title":"Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1\u20132 trial","volume":"21","author":"Davis","year":"2020","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12967-025-06346-0","article-title":"Single-cell transcriptomics reveals metabolic remodeling and functional specialization in the immune microenvironment of bone tumors","volume":"23","author":"Chen","year":"2025","journal-title":"J Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70358","article-title":"Metabolic reprogramming: A crucial contributor to anticancer drug resistance","volume":"6","author":"Zhu","year":"2025","journal-title":"MedComm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844142","article-title":"Immunotherapy: Reshape the tumor immune microenvironment","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00917-3","article-title":"A tumor microenvironment-based prognostic index for osteosarcoma","volume":"30","author":"Wu","year":"2023","journal-title":"J BioMed Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394284","article-title":"Unlocking the tumor-immune microenvironment in osteosarcoma: Insights into the immune landscape and mechanisms","volume":"15","author":"Orrapin","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155207","article-title":"Tumor-associated macrophages in osteosarcoma: From mechanisms to therapy","volume":"21","author":"Cersosimo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/cancers17132117","article-title":"Immunosuppressive tumor microenvironment of osteosarcoma","volume":"17","author":"Taylor","year":"2023","journal-title":"Cancer (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.615084","article-title":"Development of a machine learning-based autophagy-related lncRNA signature to improve prognosis prediction in osteosarcoma patients","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4117","article-title":"A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma","volume":"10","author":"Yang","year":"2021","journal-title":"Cancer Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1017120","article-title":"A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy","volume":"13","author":"Pan","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/ol.2021.12441","article-title":"Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma","volume":"21","author":"Yang","year":"2021","journal-title":"Oncol Lett"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1642525","article-title":"The multifaceted role of macrophages in kidney physiology and diseases","volume":"16","author":"Ma","year":"2025","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-021-00598-w","article-title":"The role of tumor-associated macrophages in osteosarcoma progression \u2013 therapeutic implications","volume":"44","author":"Huang","year":"2021","journal-title":"Cell Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109955","article-title":"Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors","volume":"37","author":"He","year":"2021","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"200134","DOI":"10.1183\/16000617.0134-2020","article-title":"Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment","volume":"29","author":"Zheng","year":"2020","journal-title":"Eur Respir Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114260","article-title":"The origin and polarization of macrophages and their role in the formation of the pre-metastatic niche in osteosarcoma","volume":"150","author":"Lai","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.01.023","article-title":"CD163 + M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma","volume":"34","author":"Han","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1518","article-title":"Anti\u2010PD\u20101 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases","volume":"7","author":"Dhupkar","year":"2018","journal-title":"Cancer Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00109-018-1711-0","article-title":"Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1","volume":"97","author":"Su","year":"2019","journal-title":"J Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1599","article-title":"Targeting neutrophils: Mechanism and advances in cancer therapy","volume":"14","author":"Yang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.01.006","article-title":"Neutrophil degranulation, plasticity, and cancer metastasis","volume":"40","author":"Mollinedo","year":"2019","journal-title":"Trends Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1490712","article-title":"The role of neutrophils in osteosarcoma: Insights from laboratory to clinic","volume":"15","author":"Xia","year":"2024","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1647913","article-title":"Neutrophil elastase promotes low molecular weight cyclin E1 formation to accelerate osteosarcoma proliferation","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1551074","article-title":"NETs-related genes predict prognosis and are correlated with the immune microenvironment in osteosarcoma","volume":"15","author":"Chu","year":"2025","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00432-023-05577-2","article-title":"Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model","volume":"150","author":"Tang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111364","article-title":"Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients","volume":"127","author":"Lin","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: An update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709210","article-title":"Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-012-2299-2","article-title":"Anti-TGF-\u03b2 antibody combined with dendritic cells produce antitumor effects in osteosarcoma","volume":"470","author":"Kawano","year":"2012","journal-title":"Clin Orthop"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3892\/or.2015.4161","article-title":"Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma","volume":"34","author":"Kawano","year":"2015","journal-title":"Oncol Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transd Targ Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: An emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105818","article-title":"SDF-1\/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy","volume":"75","author":"Jiang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: Expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nri3442","article-title":"The integration of T cell migration, differentiation and function","volume":"13","author":"Masopust","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion","volume":"2","author":"Franco","year":"2020","journal-title":"Nat Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142237","article-title":"Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells","volume":"212","author":"Odorizzi","year":"2015","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8 + T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1089\/dna.2017.3669","article-title":"Evidence of interleukin 21 reduction in osteosarcoma patients due to PD-1\/PD-L1-mediated suppression of follicular helper T cell functionality","volume":"36","author":"Gao","year":"2017","journal-title":"DNA Cell Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1394339","article-title":"Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies","volume":"12","author":"Liang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1925-3","article-title":"Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy","volume":"66","author":"Sundara","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512520","article-title":"Promise and challenges of T cell immunotherapy for osteosarcoma","volume":"24","author":"Park","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.006","article-title":"Natural killer cell biology: an update and future directions","volume":"132","author":"Campbell","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28167","article-title":"NK cell and macrophages confer prognosis and reflect immune status in osteosarcoma","volume":"120","author":"Yang","year":"2019","journal-title":"J Cell Biochem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008755","article-title":"CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma","volume":"13","author":"Cho","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215690","article-title":"Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma","volume":"537","author":"Ogiwara","year":"2022","journal-title":"Cancer Lett"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7299","article-title":"PD-L1\/PD-1 axis serves an important role in natural killer cell-induced cytotoxicity in osteosarcoma","volume":"42","author":"Zhang","year":"2019","journal-title":"Oncol Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.907550","article-title":"Immune microenvironment in osteosarcoma: components, therapeutic strategies and clinical applications","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011091","article-title":"Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma","volume":"13","author":"Chen","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1651858","article-title":"The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target","volume":"16","author":"Zou","year":"2025","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114492","article-title":"Glycolysis-related gene signatures and the functional role of P4HA1 in osteosarcoma prognosis","volume":"447","author":"Gui","year":"2025","journal-title":"Exp Cell Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1072","article-title":"Characterization of the tumour microenvironment phenotypes in Malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients","volume":"12","author":"Zhang","year":"2022","journal-title":"Clin Transl Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1467052","article-title":"A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.673827","article-title":"Expression of lipid-metabolism genes is correlated with immune microenvironment and predicts prognosis in osteosarcoma","volume":"9","author":"Qian","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26091","article-title":"Bulk and single-cell sequencing identified a prognostic model based on the macrophage and lipid metabolism related signatures for osteosarcoma patients","volume":"10","author":"Lin","year":"2024","journal-title":"Heliyon"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1424806","article-title":"Multi-omic validation of the cuproptosis-sphingolipid metabolism network: modulating the immune landscape in osteosarcoma","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12885-024-13278-3","article-title":"Role of arachidonic acid metabolism in osteosarcoma prognosis by integrating WGCNA and bioinformatics analysis","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.08.009","article-title":"Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities","volume":"44","author":"Borde","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051879","article-title":"Glucose metabolism and tumor microenvironment: mechanistic insights and therapeutic implications","volume":"26","author":"Andryszkiewicz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.507129","article-title":"Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect","volume":"288","author":"Giang","year":"2013","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12089","article-title":"MicroRNA-615 functions as a tumor suppressor in osteosarcoma through the suppression of HK2","volume":"20","author":"Sun","year":"2020","journal-title":"Oncol Lett"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.06.092","article-title":"PI3K\/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma","volume":"464","author":"Zhuo","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10534","article-title":"miR-185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2","volume":"20","author":"Liu","year":"2019","journal-title":"Mol Med Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.06.085","article-title":"LncRNA TUG1 affects cell viability by regulating glycolysis in osteosarcoma cells","volume":"674","author":"Han","year":"2018","journal-title":"Gene"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175799","article-title":"COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells","volume":"951","author":"Zhang","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201643300","article-title":"PKM 2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.3950","article-title":"Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2","volume":"50","author":"Shang","year":"2017","journal-title":"Int J Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-042022-031657","article-title":"Transcellular barriers to glucose delivery in the body","volume":"86","author":"Klip","year":"2024","journal-title":"Annu Rev Physiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6437","article-title":"Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma","volume":"14","author":"Fan","year":"2017","journal-title":"Oncol Lett"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001759","article-title":"Direct type I IFN but not MDA5\/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after Poly IC stimulation","volume":"12","author":"Pantel","year":"2014","journal-title":"PloS Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1515\/nanoph-2022-0289","article-title":"Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy","volume":"11","author":"Du","year":"2022","journal-title":"Nanophotonics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","article-title":"Targeting lipid metabolism of cancer cells: a promising therapeutic strategy for cancer","volume":"401","author":"Liu","year":"2017","journal-title":"Cancer Lett"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040580","article-title":"Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"key":"B96","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1038\/s41598-024-63736-y","article-title":"Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M088559","article-title":"Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells","volume":"60","author":"Roy","year":"2019","journal-title":"J Lipid Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2025.100660","article-title":"Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: from molecular mechanisms to potential targets","volume":"51","author":"Yin","year":"2025","journal-title":"J Bone Oncol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2022.5334","article-title":"LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis","volume":"60","author":"Pu","year":"2022","journal-title":"Int J Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.7150\/jca.83106","article-title":"CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation","volume":"14","author":"Tong","year":"2023","journal-title":"J Cancer"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110829","article-title":"Hsa_circ_0000073 promotes lipid synthesis of osteosarcoma through hsa-miR-1184\/ FADS2 pathway","volume":"110","author":"Ren","year":"2023","journal-title":"Cell Signal"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev Cell"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18286","article-title":"Inflammasome\u2010related gene signatures as prognostic biomarkers in osteosarcoma","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.10.006","article-title":"The fatty acid receptor CD36 promotes macrophage infiltration via p110\u03b3 signaling to stimulate metastasis","volume":"74","author":"Qin","year":"2025","journal-title":"J Adv Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.117909","article-title":"DPP7 promotes fatty acid \u03b2-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer","volume":"21","author":"Chang","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01224-z","article-title":"Regulation of CD8+ T cells by lipid metabolism in cancer progression","volume":"21","author":"Tang","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2570","article-title":"Sterol regulatory element\u2013binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity","volume":"14","author":"Kidani","year":"2013","journal-title":"Nat Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg cells promote the SREBP1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived interferon-\u03b3","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010824","article-title":"Modulating lipid metabolism improves tumor immunotherapy","volume":"13","author":"Ping","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005602","article-title":"Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment","volume":"136","author":"Kobayashi","year":"2020","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.603837","article-title":"Metabolism of amino acids in cancer","volume":"8","author":"Wei","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1582116","article-title":"Targeting amino acid in tumor therapy","volume":"15","author":"Ge","year":"2025","journal-title":"Front Oncol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine","volume":"36","author":"Zhang","year":"2017","journal-title":"EMBO J"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-020-0209-8","article-title":"Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma","volume":"8","author":"Ren","year":"2020","journal-title":"Cancer Metab"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1186\/s12967-024-05803-6","article-title":"SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K\/AKT\/mTOR signaling in osteosarcoma","volume":"22","author":"Huang","year":"2024","journal-title":"J Transl Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molcel.2016.04.033","article-title":"Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53","volume":"62","author":"Riscal","year":"2016","journal-title":"Mol Cell"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and one-carbon units: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108678","article-title":"Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma","volume":"34","author":"Rathore","year":"2021","journal-title":"Cell Rep"},{"key":"B119","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41419-025-07378-6","article-title":"PHGDH inhibition and FOXO3 modulation drives PUMA-dependent apoptosis in osteosarcoma","volume":"16","author":"Oyama","year":"2025","journal-title":"Cell Death Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2016.06.008","article-title":"A novel mechanism of mTORC1-mediated serine\/glycine metabolism in osteosarcoma development","volume":"29","author":"Wang","year":"2017","journal-title":"Cell Signal"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110609","article-title":"Metabolism drives macrophage heterogeneity in the tumor microenvironment","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.10.019","article-title":"Arginine arms T cells to thrive and survive","volume":"24","author":"Kishton","year":"2016","journal-title":"Cell Metab"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102491","article-title":"Metabolism and macrophages in the tumor microenvironment","volume":"91","author":"Yang","year":"2024","journal-title":"Curr Opin Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403019R","article-title":"Metabolic reprogramming of glycolysis, lipids, and amino acids in tumors: impact on CD8 + T cell function and targeted therapeutic strategies","volume":"39","author":"Liang","year":"2025","journal-title":"FASEB J"},{"key":"B125","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.03.004","article-title":"Glutathione restricts serine metabolism to preserve regulatory T cell function","volume":"31","author":"Kurniawan","year":"2020","journal-title":"Cell Metab"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2012.11.018","article-title":"Altered functions of natural killer cells in response to L-arginine availability","volume":"280","author":"Lamas","year":"2012","journal-title":"Cell Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110675200","article-title":"Regulation of T cell receptor CD3\u03b6 chain expression byl-arginine","volume":"277","author":"Rodriguez","year":"2002","journal-title":"J Biol Chem"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.37","article-title":"Arginine dependence of tumor cells: targeting a chink in cancer\u2019s armor","volume":"35","author":"Patil","year":"2016","journal-title":"Oncogene"},{"key":"B130","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12967-025-06086-1","article-title":"Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma","volume":"23","author":"Liao","year":"2025","journal-title":"J Transl Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100675","article-title":"Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma","volume":"20","author":"Xiang","year":"2023","journal-title":"Mater Today Bio"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400538","article-title":"Enhanced osteosarcoma immunotherapy via CaCO3 nanoparticles: remodeling tumor acidic and immune microenvironment for photodynamic therapy","volume":"13","author":"Gao","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B134","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-025-02516-2","article-title":"Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma","volume":"25","author":"Zeng","year":"2025","journal-title":"Mol Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0229-4","article-title":"Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells: a novel mechanism of cancer evasion","volume":"56","author":"Kano","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/srep37046","article-title":"Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against colon cancer","volume":"6","author":"Janakiram","year":"2016","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s13018-025-05716-0","article-title":"Identification and verification of a polyamine metabolism-related gene signature for predicting prognosis and immune infiltration in osteosarcoma","volume":"20","author":"Qiu","year":"2025","journal-title":"J Orthop Surg"},{"key":"B138","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.24.13795","article-title":"Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids","volume":"96","author":"Lepple-Wienhues","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101840","article-title":"Ceramide metabolism-related prognostic signature and immunosuppressive function of ST3GAL1 in osteosarcoma","volume":"40","author":"Zou","year":"2024","journal-title":"Transl Oncol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216893","article-title":"NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1\/CXCL8 axis","volume":"591","author":"Ji","year":"2024","journal-title":"Cancer Lett"},{"key":"B142","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1038\/s41467-022-34064-4","article-title":"Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1194094","article-title":"Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p","volume":"14","author":"Yang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-022-04980-w","article-title":"SGLT2 inhibitor activates the STING\/IRF3\/IFN-\u03b2 pathway and induces immune infiltration in osteosarcoma","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxy079","article-title":"Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects","volume":"31","author":"Uehara","year":"2019","journal-title":"Int Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaf365","article-title":"Sonodynamic therapy augmented by glycolysis inhibition: a novel metabolic reprogramming strategy for enhanced osteosarcoma treatment","volume":"12","author":"Song","year":"2025","journal-title":"Natl Sci Rev"},{"key":"B147","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/15384047.2016.1276136","article-title":"Combination therapy with L-arginine and \u03b1-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice","volume":"18","author":"He","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1186\/s12967-025-07128-4","article-title":"Hispidulin suppresses osteosarcoma by directly targeting FABP4 to disrupt lipid metabolism and inhibit the PI3K\/AKT pathway","volume":"23","author":"Yuan","year":"2025","journal-title":"J Transl Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510004","article-title":"Integrating metabolic modulation and nanomedicine for cancer immunotherapy","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202518468","article-title":"Universal antibody\u2010engineered lipid nanoparticles potentiate chemo\u2010immunotherapy against triple\u2010negative breast cancer by reprogramming tumor cell metabolism","volume":"13","author":"Dai","year":"2026","journal-title":"Adv Sci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41413-024-00359-z","article-title":"Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma","volume":"12","author":"Lacinski","year":"2024","journal-title":"Bone Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3911","article-title":"A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009160","article-title":"Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment","volume":"12","author":"O\u2019Connell","year":"2024","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1818745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:53:16Z","timestamp":1780030396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1818745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2026.1818745"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1818745","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1818745"}}